Effect of defibrotide on polymorphonuclear leukocytes: modulation of calcium entry and availability.
Di Perri
T
T
Instituto di Patologia Medica, University of Siena, Policlinico Le Scotte, Italy.
Pasini
F L
FL
D001682:Biological Availability; D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism* / Q000493:pharmacokinetics; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005609:Free Radicals; D006801:Humans; D009113:Muramidase / Q000032:analysis; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000494:pharmacology; D009504:Neutrophils / Q000187:drug effects*; D011089:Polydeoxyribonucleotides / Q000494:pharmacology*; D013481:Superoxides; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D005343:Fibrinolytic Agents; D005609:Free Radicals; D011089:Polydeoxyribonucleotides; D013481:Superoxides; D000001:Calcimycin; C036901:defibrotide; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009113:Muramidase; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium